Increase in Out-of-Pocket Costs Could Increase Abandonment of HIV PrEP Meds
By Elana Gotkine HealthDay Reporter
MONDAY, Jan. 8, 2024 -- An increase in out-of-pocket costs for HIV preexposure prophylaxis (PrEP) medications could increase abandonment of PrEP, leading to an increase in HIV diagnoses, according to a study published in the January issue of Health Affairs.
Lorraine T. Dean, Sc.D., from Johns Hopkins University in Baltimore, and colleagues estimated the risk-adjusted percentages of patients who abandoned their initial PrEP prescription across six out-of-pocket spending categories in a sample of 58,529 people with a new insurer-approved PrEP prescription. The percentage of patients who would abandon PrEP under hypothetical changes to out-of-pocket spending ranging from $0 to $500 was then simulated.
The researchers found that abandonment rates increased from 5.5 percent at $0 to 42.6 percent at >$500; there was a doubling in abandonment observed with a small increase from $0 to $10. Conversely, a decrease in abandonment rates was seen from 48.0 percent at >$500 to 7.3 percent at $0. Patients who abandoned versus filled PrEP prescriptions had a two to three times higher rate of HIV diagnoses.
"Our findings suggest that out-of-pocket cost increases for PrEP could upend the progress that has been made towards ending the HIV/AIDS epidemic in the United States," senior author Jalpa Doshi, Ph.D., from the University of Pennsylvania in Philadelphia, said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted January 2024
Read this next
Cognitive Impairment Still Seen in Children, Teens With HIV
TUESDAY, April 30, 2024 -- Cognitive impairment persists in children and adolescents living with HIV even in the era of antiretroviral therapy (ART), according to research...
Pandemic Reignited Debate Regarding Physician's Obligation to Treat
MONDAY, April 29, 2024 -- There was a surge in ethics literature during COVID-19 advocating for the ethical acceptability of physicians refusing to treat, according to a study...
Coronary Artery Vessel Wall Thickness Increased for People Living With HIV
TUESDAY, April 16, 2024 -- Asymptomatic people living with HIV (PLWH) with a low risk for cardiovascular disease have increased coronary artery vessel wall thickness (VWT)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.